ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.

Brian H Kushner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.